Srihar, Kanishta
Gusnanto, Arief
Richman, Susan D.
West, Nicholas P.
Galvin, Leanne
Bottomley, Daniel
Hemmings, Gemma
Glover, Amy
Natarajan, Subaashini
Miller, Rebecca
Arif, Sameira
Rossington, Hannah
Dunwell, Thomas L.
Dailey, Simon C.
Fontarum, Gracielle
George, Agnes
Wu, Winnie
Quirke, Phil
Wood, Henry M.
Funding for this research was provided by:
Yorkshire Cancer Research (L394)
National Institute for Health and Care Research (120400)
Article History
Received: 26 April 2024
Accepted: 6 September 2024
First Online: 19 September 2024
Competing interests
: This study was part funded by GeneFirst through a national Institute of Health i4i grant to evaluate the technology. PQ declares other research funding from Roche and Oxford Nanoinstruments unconnected with this work. TLD, SCD, GF, AG and WW are direct employees of GeneFirst Ltd. KS, AG, SR, NW, LG, DB, GH, AG, SN, RM, SA, HR, HW—no disclosures.